Table 2.
Select literature reports summarizing progress in MR of BAT morphology and metabolic activity.
| MR Technique(s) | First-Author (Ref. Number) | Morphology, Metabolic Activity | Magnetic Field Strength | Rodent, Human | MR Findings | Significance to MR |
|---|---|---|---|---|---|---|
|
* Proton MRS and T1/T2-Weighted MRI
** Proton MRS *** Proton MRS and CSI |
* Osculati (181, 182) | Morphology | 7.0 Tesla | rodent ex vivo specimen / in vivo | Higher water content in BAT. BAT is consistently hypointense to WAT on conventional MRI. | Difference in fat-to-water ratio of BAT and WAT contributes to difference in signal intensities in MR BAT intensity potentially indicative of underlying adipocyte structure and fat content. Physiology and metabolism-mediated differences in TG properties between BAT and WAT exist and can be quantified by MR. |
| ** Zancanaro (186) | 11.7 Tesla | rodent ex vivo specimen | BAT is more saturated. Unsaturation levels vary with age, temperature, and stimulation. | |||
| ** Strobel (60) | 7.0 Tesla | rodent in vivo | BAT and WAT have different water and fat contents. BAT is more saturated than WAT. Measured T2 of individual TG peaks. | |||
| ** Hamilton (185) | 3.0 Tesla | rodent ex vivo specimen | BAT and WAT have different water and fat contents. BAT is more saturated than WAT. Measured T1 and T2 of individual peaks. | |||
| *** Lunati (75) | 4.7 Tesla | rodent post-mortem / in vivo | BAT is more polyunsaturated than WAT. Polyunsaturation degree is more uniform in BAT. | |||
|
* T1/T2-weighted MRI and Frequency-Selective MRI
** T1/T2- weighted MRI |
* Dundamadappa (179) | not reported | human in vivo | BAT hyperintense versus muscle. BAT signal intensity is variable on fat-suppressed images. | BAT can be visualized on T1 and T2 weighted images and exhibit signal intensity differences in comparison to muscle and WAT. | |
| ** Carter (180) | BAT iso- and hyperintense to muscle and hypointense to fat on T1 and T2 -weighted images. | |||||
| ** Sbarbati (183) | Morphology and Metabolic Activity | 4.7 Tesla | rodent in vivo | BAT exhibits lower signals in cold-acclimated animals than those at thermoneutrality. BAT shows decrease in signal after stimulation. | BAT MR signals sensitive to temperature and stimulation. | |
| * Chen (184) | 9.4 Tesla | BAT has a shorter T2 than WAT, and is less affected by fat-suppression. BAT perfusion visible with MR contrast agent; hemodynamics visible with fMRI. | Characterization of BAT morphology and function is feasible with MR. | |||
|
* Proton MRS and Frequency-Selective MRI
** Frequency-Selective MRI |
* Sbarbati (187) | Morphology | 4.7 Tesla | Evident differences in water-fat spectra and signals between muscle, BAT, and WAT. | Works posit and reinforce fat-signal fraction as a useful biomarker for comparing BAT and WAT and for comparing BAT between groups. | |
| ** Lunati (188) | Interscapular BAT has varying fat-signal fractions from surface to intermediate and deep layers. | |||||
| * Peng (189) | 7.0 Tesla | Consistent cross-sectional differences in BAT and WAT fat-signal fractions between groups. | ||||
| Proton Spectroscopy | Branca (202) | 7.0 Tesla | rodent ex vivo specimen / in vivo | Novel approach exploits proximity of water and fat in BAT to generate spectral signal. Relies also on the presence of water and fat in BAT. | Method overcomes intrinsic limitation of spatial resolution and partial-volume effects. | |
| Chemical-Shift-Encoded Water-Fat MRI | Hu (190, 191) | 3.0 Tesla | rodent ex vivo specimen / post-mortem / in vivo | BAT consistently occupies a lower and broader fat-signal fraction range than WAT. | Reinforces earlier works that fat-signal fraction contrast between BAT and WAT is potentially a useful biomarker, and that signal trends are consistent between rodents and humans. BAT fat-signal fraction potentially useful in cross-sectional group comparisons. |
|
| Smith (192) | 9.4 Tesla | rodent in vivo | ||||
| Holstila (193) | 1.5 Tesla | rodent - post-mortem human - in vivo | ||||
| Hu (194, 195, 196) | 3.0 Tesla | human post-mortem / in vivo | ||||
| Lidell (197) | human post-mortem | |||||
| Gifford (198) | human in vivo | |||||
| Wayte (199) | ||||||
| Lundström (200) | 1.5 Tesla | |||||
| T2*-weighted MRI | Khanna (228) | Metabolic Activity | 7.0 Tesla | rodent in vivo | Variations in BAT metabolic activity due to temperature and drug stimulations are detectable by dynamic T2* MRI, relying on the BOLD effects of hemoglobin and tissue perfusion. | BAT function and hemo-dynamics can be monitored using MRI, without the use of a contrast agent. |
| van Rooijen (201) | 3.0 Tesla | human in vivo | ||||
| 13-Carbon Spectroscopy and CSI | Lau (230) | rodent in vivo | BAT metabolic activity can be quantified with hyperpolarized 13C-pyruvate and its downstream products, bicarbonate, alanine, and lactate. | BAT metabolism and function can be quantified with MR with the administration of emerging exogenous contrast agents. | ||
| Friesen-Waldner (231) | ||||||
| 129-Xenon Spectroscopy and CSI | Branca (232, 233) | 9.4 Tesla | BAT metabolic activity can be quantified with 129Xe in gas, lipid-, and cytoplasm-dissolved phases, and the chemical-shift of 129Xe due to temperature. |